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ABSTRACT
Aims/Introduction: Resistin, secreted from adipocytes, causes insulin resistance in mice.
In humans, the resistin gene is mainly expressed in monocytes and macrophages. Tuni-
camycin is known to induce endoplasmic reticulum (ER) stress, and reduce resistin gene
expression in 3T3-L1 mouse adipocytes. The aim of the present study was to examine
whether ER stress affects resistin gene expression in human monocytes.
Materials and Methods: The relationship between resistin messenger ribonucleic acid
(mRNA) and ER stress markers mRNA was analyzed by reverse transcription polymerase
chain reaction in isolated monocytes of 30 healthy volunteers. The effect of endotoxin/
lipopolysaccharides or tunicamycin on resistin gene expression was analyzed in THP-1
human monocytes. Signaling pathways leading to resistin mRNA were assessed by the
knockdown using small interfering RNA or overexpression of key molecules involved in
unfolded protein response.
Results: Resistin mRNA was positively associated with immunoglobulin heavy chain-
binding protein (BiP) or CAAT/enhancer binding protein-a homologous protein (CHOP)
mRNA in human isolated monocytes. In THP-1 cells, lipopolysaccharides increased mRNA
of BiP, pancreatic endoplasmic reticulum eukaryotic initiation factor 2a kinase (PERK) and
CHOP, as well as resistin. Tunicamycin also increased resistin mRNA. This induction
appeared to be dose- and time-dependent. Tunicamycin-induced resistin mRNA was
inhibited by chemical chaperone, 4-phenylbutyric acid. The knockdown of either PERK,
activating transcription factor 4 (ATF4) or CHOP reduced tunicamycin-induced resistin
mRNA. Conversely, overexpression of ATF4 or CHOP increased resistin mRNA.
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ORIGINAL ARTICLE
Conclusions: Endoplasmic reticulum stress induced by tunicamycin increased resistin
mRNA through the PERK–ATF4–CHOP pathway in THP-1 human monocytes. ER stress
could lead to insulin resistance through enhanced resistin gene expression in human
monocytes.
INTRODUCTION
Resistin is secreted from adipocytes in mice, and its serum
levels have been reported to be increased in obese diabetic
mice1,2. Treatment with peroxisome proliferator-activated recep-
tor-c (PPAR-c) ligands reduces serum resistin in mice. Mice
that overexpress the mouse resistin gene (retn) in the liver have
high serum resistin and are insulin resistant3. Retn (-/-) mice
show lower insulin resistance and fasting blood glucose4. In
humans, the human resistin gene (RETN) is not expressed in
adipocytes, but is highly expressed in monocytes and macro-
phages5, suggesting that its pathophysiological relevance might
be different between humans and mice.
We previously carried out a systematic search for single
nucleotide polymorphisms (SNPs) in RETN, and reported that
the G/G genotype of a promoter SNP at -420 was associated
with susceptibility to type 2 diabetes mellitus6,7. In addition, we
reported that subjects with type 2 diabetes mellitus had higher
plasma resistin than subjects without type 2 diabetes mellitus8.
In the Japanese general population, plasma resistin was highest
in the G/G genotype, followed by C/G and C/C9.
Recent studies have shown that resistin is related to inﬂam-
mation. Pro-inﬂammatory stimuli, such as interleikin-6, tumor
necrosis factor-a (TNF-a) and lipopolysaccharides (LPS),
induce RETN expression in primary human macrophages or
humans peripheral blood mononuclear cells (PBMC)10,11. In
addition, on tissue injury, pro-inﬂammatory stimuli increased
the expression of monocyte chemoattractant protein (MCP)-1/
CCL2 gene, which could trigger endoplasmic reticulum (ER)
stress, caused by the accumulation of unfolded or misfolded
proteins in the ER lumen12–14. Therefore, resistin gene expres-
sion could be inﬂuenced by ER stress as well as by inﬂamma-
tion, based on current information.
Eukaryotic cells have an intracellular signaling pathway for
reducing ER stress, known as the unfolded protein
response15,16. When unfolded or misfolded proteins accumulate,
glucose regulated protein 78, also referred to the immunoglobu-
lin heavy chain-binding protein (BiP), releases three critical
transmembrane ER signaling proteins, namely, pancreatic ER
eukaryotic initiation factor 2 (eIF2) a kinase (PERK), activating
transcription factor (ATF) 6, and the inositol requiring enzyme
(IRE) 117–19. PERK phosphorylates the a-subunit of eIF2a and
suppresses protein translation. In contrast, PERK selectively
promotes the translation of ATF4, which induces the expres-
sion of several genes involved in restoring ER homeostasis. The
activation of IRE1 leads to splicing of X-box binding protein 1
(XBP1) messenger ribonucleic acid (mRNA). XBP1 is a
transcription factor that induces the expression of several genes
involved in ER-associated degradation. ATF6 induces XBP1
gene transcription, and upregulates the formation of ER molec-
ular chaperons, which, in turn, facilitate protein folding with
IRE120,21. However, when ER stress is prolonged or excessive,
unfolded protein response is closely interconnected with pro-
inﬂammatory pathways and/or apoptosis, through the overex-
pression of CAAT/enhancer binding protein-a (C/EBP) homol-
ogous protein (CHOP), the PERK/ATF4-dependent
transcription factor. As a result, the cells are unable to maintain
ER homeostasis, and ﬁnally undergo apoptotic cell death22.
The effect of ER stress on retn expression has been studied in
3T3-L1 mouse adipocytes, where the opposite effects were
observed. Lefterova et al.23 reported that tunicamycin, an inducer
of ER stress, reduced resistin mRNA and protein by suppressing
resistin activators, C/EBP and PPAR-c, in 3T3-L1 adipocytes24,25.
In contrast, Chen et al.26 reported that oxidized low-density
lipoprotein, another ER stress inducer, increased retn expression
and protein through the upregulation of BiP and CHOP in 3T3-
L1 adipocytes27. As the expression of the resistin gene is clearly
different between humans and mice, the relationship between ER
stress and resistin in human monocytes should be pursued.
In view of this, to elucidate whether ER stress affects RETN
expression in humans, we examined the relationship between
ER stress and RETN expression in isolated human monocytes
and THP-1 human monocytes. The ﬁndings show that ER
stress induced by tunicamycin increased resistin mRNA through
the PERK–ATF4–CHOP pathway in THP-1 human monocytes.
MATERIALS AND METHODS
Participants
A total of 30 healthy volunteers (11 men and 19 women, age
23.8 – 2.9 years [range 21–31 years], body mass index
20.3 – 1.5 [range 17.7–23.3 years]) were analyzed. They had a
normal glucose tolerance, as assessed by a 75-g oral glucose tol-
erance test. Their routine blood tests were within normal
ranges. All participants were informed of the purpose of the
study and their consent was obtained. The study was approved
by the ethics committee of the Ehime University Graduate
School of Medicine.
Isolation of human monocytes
Peripheral mononuclear cells were collected from whole blood
using a Lymphoprep Tube (Axis-Shield PoC AS, Oslo, Nor-
way), and monocytes were isolated from the mononuclear cells
using an anti-CD14 antibody of the MACS system (Miltenyi
Biotec GmbH, Bergisch Gladbach, Germany).
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Cell culture and treatment
The human monocytic cell line derived from an acute mono-
cytic leukemia patient, THP-1, was purchased from JCRB
(Osaka, Japan) and cultured in Roswell Park Memorial Institute
Medium 1640 (Life Technologies, Paisley, UK) supplemented
with 10% fetal bovine serum (Life Technologies), 2 mmol/L L-
glutamine, 50 U/mL penicillin and 50 lg/mL streptomycin.
THP-1 cells were grown in a humidiﬁed 5% CO2 atmosphere
at 37°C. For experiments with inﬂammation, THP-1 cells
(2 9 105 cells/mL) were treated with 100 ng/mL LPS (Sigma-
Aldrich, St. Louis, MO, USA) for 24 h. For experiments with
ER stress, THP-1 cells (3 9 105 cells/mL) were treated with
0.01, 0.1, or 1.0 lg/mL tunicamycin (Sigma-Aldrich) for 4, 8,
12, 24, 48 or 72 h. Pharmacological inhibition of ER stress was
achieved by preincubating THP-1 cells with the chemical chap-
erone 4-phenylbutyric acid (4-PBA; Sigma-Aldrich, Steinheim,
Germany) at a ﬁnal concentration of 0.75, 1.5, 3.0 or
7.5 mmol/L for 14 h. After this pretreatment, the cells were
treated with 0.1 lg/mL tunicamycin for 24 h.
RNA isolation, reverse transcription and real-time polymerase
chain reaction
Total RNA was isolated from THP-1 cells using a RNeasy
Mini Kit (QIAGEN, Hilden, Germany). The concentration and
purity (A260/A280 ratio) of RNA were determined by Nano-
Drop 2000 (Thermo Fisher Scientiﬁc, Waltham, MA, USA).
First-strand complementary deoxyribonucleic acid (DNA) was
synthesized from 0.5 lg of total RNA using a High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems, Foster
City, CA, USA). Reverse transcription polymerase chain reac-
tion (RT–PCR) was carried out using 12.5 lL of Taqman
Universal Master Mix (Applied Biosystems), 1 lL of Taqman
Gene Expression Assays (Applied Biosystems) and RNase free
water to a ﬁnal volume of 25 lL. PCR ampliﬁcation was car-
ried out in an ABI 7500 RT–PCR System (Applied Biosystems)
with the cycle conditions (initial cycle at 50°C for 2 min, initial
denaturation at 95°C for 10 min, 40 cycles of denaturation at
95°C for 15 s and annealing/extension at 60°C for 1 min). Rel-
ative RNA levels were calculated by the 2-DDCt method using
18S ribosomal RNA or glyceraldehyde 3-phosphate dehydroge-
nase as the internal control. The following primers were pur-
chased from Applied Biosystems and used for RT–PCR:
glyceraldehyde 3-phosphate dehydrogenase (Hs99999905_m1),
18S (Hs99999901_s1), RETN (Hs00220767_m1), BiP/HSPA5
(Hs00607129_gH), PERK/EIF2AK3 (Hs00984005_m1), ATF4
(Hs00909569_g1), CHOP/DDIT3 (Hs00358796_g1), ATF6a
(Hs00232586_m1), IRE1a/ERN1 (Hs00176385_m1) and XBP1
(Hs00231936_m1).
Small interfering RNA transfection
Small interfering RNA (siRNA) oligos targeting PERK, ATF4,
CHOP, ATF6, IRE1, XBP1 and a non-target negative control
were purchased from Sigma-Aldrich (St. Louis, MO, USA).
THP-1 cells were transfected with siRNA using Ingenio
Electroporation Kits and Solution (Mirus Bio Corporation,
Madison, WI, USA). The siRNA complexes with 2.5 9 106
THP-1 cells and 500 nmol/L siRNA in 250 lL Ingenio Solu-
tion were made and electroporated with a voltage of 250 V
and a capacitance of 950 lF using a 0.4-cm cuvette. Thereafter,
electroporated cells were added to 50 lL of fresh serum-con-
taining medium in 24-well plates and treated with 0.1 lg/mL
tunicamycin for 24 h. The following siRNA were used: negative
control (Mission_SIC-001), PERK (Hs_EIF2AK3_6845), ATF4
(Hs_ATF4_2313), CHOP (Hs_DDIT3_3015), ATF6 (Hs_
ATF6_3439), IRE1 (Hs_ERN1_4923) and XBP1 (Hs_XBP1_
3590).
Overexpression of ATF4 and CHOP
The expression vectors, pCMV6-XL5 containing the coding
sequence of human ATF4 (SC119103), and pCMV6-AC con-
taining the coding sequence of human CHOP (SC324377),
were purchased from OriGene Technologies, Inc (Rockville,
MD, USA). THP-1 cells were transfected with 20 lg of plasmid
DNA using Ingenio Electroporation Kits and Solutions. The
complexes with 2.5 9 106 THP-1 cells and 20 lg of plasmid
in 250 lL Ingenio Solution were made and electroporated
with a voltage of 250 V and a capacitance of 950 lF using a
0.4-cm cuvette. Thereafter, electroporated cells were added to
50 lL of fresh serum-containing medium in 24-well plates and
allowed to grow for 48 h. It was estimated that at least approxi-
mately 17% of the THP-1 cells overexpressed introduced genes
by transfection (Figure S1).
Measurements of resistin protein
Cell Lysis
After speciﬁc treatments, THP-1 cells frozen with liquid nitro-
gen were lysed using Cell Lysis Buffer (20 mmol/L Tris-HCl
[pH 7.5], 150 mmol/L NaCl, 1 mmol/L Na2 ethylenediaminete-
traacetic acid, 1 mmol/L ethylene glycol tetraacetic acid, 1%
Triton, 2.5 mmol/L sodium pyrophosphate, 1 mmol/L beta-gly-
cerophosphate, 1 mmol/L Na3VO4, 1 lg/mL leupeptin and
1 mmol/L phenylmethylsulfonyl ﬂuoride) with cOmplete Mini
protease inhibitor (Roche Applied Science, Mannheim, Ger-
many). The cells were subjected to three cycles of freezing and
thawing, and subsequently stirred at 4°C for 1 h. Thereafter,
the cells were centrifuged at 14,000 g at 4°C for 10 min. Total
cell protein was quantiﬁed using the collected supernatant on a
Spectrophotometer (Beckman Coulter, Inc., Fullerton, CA,
USA).
Human resistin and antibodies for ultrasensitive enzyme-linked
immunosorbent assay
Human resistin and mouse anti-human resistin monoclonal
antibody (184320; Ab-resistin-1) were purchased from R&D
Systems, Inc. (Minneapolis, MN, USA). Rabbit (anti-2,4-dinitro-
phenyl [DNP]-BSA) serum and bovine serum albumin (BSA;
fraction V) were purchased from Shibayagi Co., Ltd.
(Shibukawa, Japan) and Intergen Co. (Purchase, NY, USA),
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respectively. Mouse anti-human resistin monoclonal antibody
(5G51B22; Ab-resistin-2) was prepared by ourselves. In brief,
human resistin complementary DNA (CCDS 12182.1) was
ampliﬁed using PCR from human leukocytes RNA and sub-
cloned into the pEU-GST(TEV)-N2 vector28. Glutathione S-
transferase (GST)-tagged recombinant human resistin protein
was automatically synthesized by the Robotic Protein Synthe-
sizer Protemist DT II (CellFree Sciences, Matsuyama, Japan)
according to a cell-free protein synthesis system using wheat
germ ribosomal RNA29,30. Monoclonal antibodies were raised
against the GST-tagged resistin based on the mouse spleen
method. Further information for the preparation of the mono-
clonal antibody is available on request.
Ultrasensitive enzyme-linked immunosorbent assay, immune
complex transfer enzyme immunoassay, for human resistin
Immune complex transfer enzyme immunoassay for human
resistin was carried out by following the established method
previously described31,32. Precisely, an aliquot (100 lL) of stan-
dard human resistin or samples diluted in buffer A (10 mmol/
L sodium phosphate buffer (pH 7.0), containing 0.4 mol/L
NaCl, 0.1 g/L BSA, 1 mmol/L MgCl2 and 1.0 g/L NaN3) was
incubated overnight at 4°C with 100 lL buffer A containing
30 fmol of Ab-resistin-2 Fab’-b-D-galactosidase, and 10 fmol
Ab-resistin-1 immunoglobulin G2b conjugated with DNP and
biotin (formation). Thereafter, one polystyrene bead coated with
rabbit anti-DNP-BSA immunoglobulin G was added to the
mixture and incubated for 30 min (entrapment). After remov-
ing the incubation mixture, the polystyrene bead was washed
twice with buffer B (10 mmol/L sodium phosphate buffer
[pH 7.0], containing 0.1 mol/L NaCl, 1.0 g/L BSA, 1.0 mmol/L
MgCl2 and 1.0 g/L NaN3) and then incubated in 150 lL
buffer B containing 2 mmol/L eN-2,4-DNP-L-lysine for 30 min
(elution). After removal of the polystyrene bead, one strepta-
vidin-coated polystyrene bead was added to the eluate and
incubated for 30 min (transfer). The bead was then washed,
and the bound b-D-galactosidase activity was assayed ﬂuoro-
metrically with 4-methylumbelliferyl-b-D-galactoside
(0.2 mmol/L) as a substrate for 20 h at 30°C. The incubations
with polystyrene beads were carried out with shaking at
210 strokes/min at room temperature throughout. The within-
assay and between-assay coefﬁcient variations (CVs) for resistin
were 5.2–9.7% (n = 5) and 5.0–9.7% (n = 5), respectively. The
detection limit and sensitivity for resistin were 0.003 pg/mL
and 0.15 pg/mL of medium sample, respectively. The detection
limit was 1000-fold less than that of conventional enzyme-
linked immunosorbent assay. A typical calibration curve of
immune complex transfer enzyme immunoassay for resistin is
shown in Figure S2.
Statistical analysis
ANOVA with Scheffe’s test or unpaired Student’s t-test was used
for statistical analyses. Simple regression analyses were used for
correlation between resistin mRNA and ER stress markers
mRNA in human monocytes. These analyses were carried out
using Excel 2010 (Microsoft, Seattle, WA, USA) with the add-
in software Statcel 333. Differences between groups were consid-
ered to be statistically signiﬁcant at values of P < 0.05. All
results are reported as the mean – the standard error of the
mean (SEM).
RESULTS
Resistin mRNA was positively correlated with BiP or CHOP
mRNA in human isolated monocytes
To examine the relationship between RETN expression and ER
stress in human monocytes, we ﬁrst analyzed the mRNA of
resistin and ER stress marker genes, BiP and CHOP, in isolated
monocytes obtained from the 30 healthy volunteers. Resistin
mRNA was positively correlated with either BiP or CHOP
mRNA (R = 0.453, P < 0.05, and R = 0.420, P < 0.05, respec-
tively) (Figure 1a,b). Therefore, resistin mRNA could be
induced by ER stress in human monocytes.
LPS increased resistin, BiP, PERK and CHOP mRNA in THP-1
human monocytes
We next examined whether LPS affected ER stress markers as
well as resistin mRNA in THP-1 human monocytes. Resistin
mRNA was increased to ~1.5-fold in the presence of 100 ng/
mL of LPS within 24 h (Figure 2). LPS also enhanced mRNA
of the ER stress markers, BiP, PERK and CHOP. Therefore,
LPS increased resistin and ER stress markers mRNA in THP-1
human monocytes under the same conditions.
ER Stress, induced by tunicamycin, increased resistin mRNA in
THP-1 human monocytes
To determine whether ER stress affected resistin mRNA, we
examined the effect of tunicamycin, which induces ER stress
by inhibiting N-linked glycosylation, in THP-1 human mono-
cytes. Tunicamycin treatment increased resistin mRNA for
24 h (Figure 3a). This induction appeared to be dose-depen-
dent, and reached a maximum for 0.1 lg/mL of tunicamycin.
We then examined the time-course for this using a concentra-
tion of tunicamycin of 0.1 lg/mL. The induction of resistin
mRNA by tunicamycin appeared to be time-dependent up to
24 h, and then declined to 48 h (Figure 3b). The mRNA of
ER stress markers, except for ATF6, was also enhanced by
tunicamycin for 24 h (Figure 3c). Therefore, tunicamycin,
which induces ER stress, increased resistin mRNA in THP-1
human monocytes. Similarly, thapsigargin, another ER stress
inducer, increased resistin mRNA in THP-1 human monocytes
(Figure S3a).
4-phenylbutyrate, a chemical chaperone, reduced
tunicamaycin-induced resistin and ER stress markers mRNA in
THP-1 human monocytes
We examined the effect of 4-phenylbutyrate (4-PBA), a chemi-
cal chaperone of ER stress, on resistin and ER stress markers
mRNA. The 4-PBA inhibited the tunicamycin-induced mRNA
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of the ER stress markers, BiP, PERK, ATF4, CHOP, IRE1 and
XBP1 (Figure 4a). Resistin mRNA induced by tunicamycin was
also reduced by 4-PBA (Figure 4b). These effects of 4-PBA
appeared to be dose-dependent. The mRNA of resistin and ER
stress markers in THP-1 cells without tunicamysin treatment
was not affected by 4-PBA (data not shown). Therefore, the 4-
PBA reduced tunicamaycin-induced resistin and ER stress
markers mRNA in THP-1 human monocytes.
Knockdown of PERK, ATF4 or CHOP inhibited tunicamycin-
induced resistin mRNA in THP-1 human monocytes
To determine the signaling pathway responsible for tuni-
camycin-induced resistin mRNA, siRNA of key molecules
involved in ER stress was used. The siRNA of PERK inhibited
tunicamycin-induced resistin mRNA in THP-1 human mono-
cytes (Figure 5a). The siRNA of downstream molecules, ATF4
or CHOP, also reduced tunicamycin-induced resistin mRNA
(Figure 5b,c). The siRNA of PERK, ATF4 or CHOP blocked its
own mRNA. Resistin mRNA was not affected by the siRNA of
ATF6, IRE1 or XBP1, whereas their own mRNA was reduced
(Figure S4). Therefore, the PERK–ATF4–CHOP pathway
appears to be involved in tunicamycin-induced resistin mRNA
in THP-1 monocytes.
Overexpression of ATF4 or CHOP increased resistin mRNA in
THP-1 human monocytes
To conﬁrm the involvement of ATF4 and CHOP in the induc-
tion of resistin mRNA, the effect of the transient overexpression
of ATF4 or CHOP was examined. ATF4 and CHOP were
overexpressed (Figure 6a,b). ATF4 increased resistin mRNA by
1.52-fold compared with controls (Figure 6a). Likewise, CHOP
induced resistin mRNA by 1.25-fold (Figure 6b). Therefore,
ATF4 and CHOP, downstream molecules of PERK in the ER
stress signaling pathway, were involved in the tunicamycin-
induced resistin mRNA in THP-1 human monocytes.
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Figure 1 | Resistin messenger ribonucleic acid (mRNA) was positively
correlated with immunoglobulin heavy chain-binding protein (BiP) or
CAAT/enhancer binding protein-a homologous protein (CHOP) mRNA
in human isolated monocytes. The mRNA of resistin, BiP and CHOP in
isolated monocytes of 30 healthy volunteers were quantitated using
reverse transcription polymerase chain reaction as described in
Materials and Methods. The mRNA was corrected by human
glyceraldehyde 3-phosphate dehydrogenase mRNA in each sample for
meaningful comparison. The relative mRNA of resistin, BiP and CHOP
was determined by calculating from the threshold cycles. Simple
regression analyses were used for statistical analyses. (a) BiP (R = 0.453,
P < 0.05). (b) CHOP (R = 0.420, P < 0.05).
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Figure 2 | Lipopolysaccharides (LPS) increased resistin, immunoglobulin
heavy chain-binding protein (BiP), pancreatic endoplasmic reticulum
eukaryotic initiation factor 2a kinase (PERK) and CAAT/enhancer
binding protein-a homologous protein (CHOP) messenger ribonucleic
acid (mRNA) in THP-1 human monocytes. THP-1 human monocytes
were treated with 100 ng/mL LPS for 24 h. The mRNA of human
resistin and endoplasmic reticulum stress markers, BiP, PERK and CHOP
was quantitated using reverse transcription polymerase chain reaction
as described in the Materials and Methods. Each mRNA is shown
relative to 18S rRNA mRNA. Each mRNA of the control was defined as
1.0. The mean – standard error of the mean of six separate
experiments with triplicate samples is shown. *P < 0.0005 vs control
(unpaired Student’s t-test). RETN, human resistin gene.
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Intracellular resistin protein appeared to be enhanced by
tunicamycin in THP-1 human monocytes
We next measured resistin protein in the cell lysate of THP-1
cells treated with or without 0.1 lg/mL tunicamycin for 6, 12
or 24 h. Resistin protein in the cell lysate treated without tuni-
camycin was lower at 24 h than 0 h (Figure 7). In contrast,
resistin protein in the cell lysate treated with tunicamycin was
maintained at 24 h. When the fold induction of resistin protein
by tunicamycin was compared at each time-point, this induc-
tion was higher at 24 h than 0 and 6 h. Therefore, intracellular
resistin protein appeared to be enhanced under tunicamycin-
induced ER stress in THP-1 human monocytes at at least 24 h.
Figure 4 | The 4-phenylbutyrate (4-PBA) reduced tunicamaycin-induced resistin and ER stress markers messenger ribonucleic acid (mRNA) in THP-1
human monocytes. THP-1 cells were pre-incubated with 750, 1,500, 3,000 or 7,500 μmol/L of 4-PBA, a chemical chaperone, for 14 h, and
0.1 μg/mL tunicamycin was subsequently added to the medium for 24 h. The mRNA of (a) endoplasmic reticulum stress markers (immunoglobulin
heavy chain-binding protein [BiP], pancreatic endoplasmic reticulum eukaryotic initiation factor 2a kinase [PERK], activating transcription factor 4
[ATF4], CAAT/enhancer binding protein-a homologous protein [CHOP], ATF6, inositol requiring enzyme 1 [IRE1] and X-box binding protein 1
[XBP1]) and (b) resistin (RETN) were quantitated using reverse transcription polymerase chain reaction and shown relative to 18S rRNA mRNA as
described in the Materials and Methods. The mRNA of control (4-PBA [–], tunicamycin [–]) was defined as 1.0. The mean – standard error of the
mean of five separate experiments with triplicate samples is shown. ANOVA; P = 8.49 9 10-8 (BiP), P = 0.00040 (PERK), P = 2.46 9 10-6 (ATF4),
P = 1.53 9 10-5 (CHOP), P = 0.00085 (ATF6), P = 0.0070 (IRE1), P = 0.00016 (XBP1), P = 5.44 9 10-6 (RETN); Scheffe’s test; ††P < 0.01, †P < 0.05 vs
control (tunicamycin [–], 4-PBA [–]), **P < 0.01, *P < 0.05.
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Figure 3 | Endoplasmic reticulum stress, induced by tunicamycin,
increased resistin messenger ribonucleic acid (mRNA) in THP-1 human
monocytes. (a) Tunicamycin increased resistin mRNA in THP-1 human
monocytes (dose–response). THP-1 cells were treated with 0 (control),
0.01, 0.1 or 1.0 μg/mL tunicamycin for 24 h. The mRNA of human
resistin was quantitated using reverse transcription polymerase chain
reaction, and the data are shown relative to 18S rRNA mRNA as
described in the Materials and Methods. The mRNA of the control was
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experiments with triplicate samples is shown. ANOVA and Scheffe’s test
were used for statistical analyses. ANOVA; P = 0.0014, Scheffe’s test;
*P < 0.01 compared with control, †P < 0.05 compared with
0.01 μg/mL tunicamycin. (b) (Time-course) THP-1 cells were treated
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tunicamycin. (c) The mRNA of endoplasmic reticulum stress markers,
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endoplasmic reticulum eukaryotic initiation factor 2a kinase (PERK),
activating transcription factor 4 (ATF4), CAAT/enhancer binding protein-
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box binding protein 1 (XBP1) was increased by tunicamycin. THP-1
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control (tunicamycin [–], 24 h) was defined as 1.0. The
mean – standard error of the mean of six separate experiments with
triplicate samples is shown. Unpaired Student’s t-test was used for
statistical analyses. *P < 0.01, **P < 0.001 vs control.
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Tunicamycin decreased resistin protein secretion from THP-1
human monocytes
Finally, we measured the amount of resistin protein secreted
from THP-1 cells into the medium. THP-1 cells were treated
with or without 0.1 lg/mL tunicamycin for 6, 12 or 24 h.
Paradoxically, the resistin protein in the medium was lower
with tunicamycin treatment at 12 and 24 h (Figure 8). There-
fore, tunicamycin decreased resistin protein secreted from
THP-1 human monocytes, while increasing resistin mRNA,
and possibly protein in these cells.
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Figure 5 | The knockdown of pancreatic endoplasmic reticulum eukaryotic initiation factor 2a kinase (PERK), activating transcription factor 4 (ATF4)
or CAAT/enhancer binding protein-a homologous protein (CHOP) inhibited tunicamycin-induced resistin messenger ribonucleic acid (mRNA) in
THP-1 human monocytes. THP-1 cells were transfected with each of 500 nmol/L small interfering RNA (siRNA), and 0.1 μg/mL tunicamycin was
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DISCUSSION
We have shown that ER stress markers mRNA was positively
associated with resistin mRNA in isolated human monocytes.
ER stress induced by tunicamycin also increased resistin mRNA
in THP-1 human monocytes. The PERK–ATF4–CHOP path-
way was involved in this increase, as evidenced by knockdown
using siRNA and the overexpression of key molecules associ-
ated with ER stress.
In the present study, resistin mRNA was positively associated
with mRNA of ER stress markers, BiP and CHOP, in isolated
monocytes from healthy volunteers. We previously reported
that plasma resistin was positively correlated with insulin resis-
tance in the Japanese general population9. In addition, Degas-
peri et al.34 reported that activated ER stress was observed in
monocytes from obese patients compared with healthy controls.
Most recently, Gregor et al.35 reported that mRNA of the ER
stress markers, BiP and spliced XBP-1, was decreased in subcu-
taneous abdominal adipose tissues in obese subjects, when insu-
lin resistance was improved by weight loss after gastric bypass
surgery. Therefore, ER stress appears to be positively associated
with resistin mRNA in human monocytes, as well as insulin
resistance.
We found that LPS, a typical inducer of RETN expression,
also increased mRNA of BiP, PERK and CHOP in THP-1
human monocytes. Lehrke et al.11 reported that LPS increased
RETN expression in primary human macrophages, which was
inhibited by anti-inﬂammatory drugs or the PPAR-c ligand.
Therefore, inﬂammatory stimuli, such as LPS, could induce
resistin mRNA through ER stress in human monocytes.
We found that ER stress induced by tunicamycin increased
resistin mRNA in THP-1 human monocytes. This induction
appeared to be time-dependent for periods of up to 24 h, and
then declined to 48 h. Cell death caused by ER stress-induced
apoptosis could account for this decline. In contrast, previous
studies have reported that the expression of retn was downreg-
ulated by LPS or tunicamycin-induced ER stress in 3T3-L1
mouse adipocytes23,36. The opposite effects of LPS or tuni-
camycin between human monocytes and mouse adipocytes sug-
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deoxyribonucleic acid, pCMV6-XL5 containing the coding sequence of human ATF4 or pCMV6-AC containing the coding sequence of human
CHOP, and were subsequently incubated in the medium for 48 h. The mRNA of ATF4, CHOP and resistin (RETN) was quantitated using reverse
transcription polymerase chain reaction and shown relative to 18S rRNA mRNA as described in the Materials and Methods. The mRNA of the
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gest that resistin gene expression was differentially regulated
between these cells.
We showed that 4-PBA reduced tunicamycin-induced resis-
tin mRNA in THP-1 cells. The 4-PBA also inhibited tuni-
camycin-induced mRNA of typical molecules involved in ER
stress in THP-1 cells. The 4-PBA is known to be a representa-
tive chemical chaperone of ER stress, and functions to reduce
the ER stress-induced phosphorylation of PERK and IRE-1,
and the splicing of XBP1 mRNA in the liver of ob/ob mice37,38.
Kawasaki et al.39 reported that 4-PBA inhibited the gene
expression of inﬂammatory cytokines induced by a high-fat diet
through ER stress in mice. Zeng et al.40 reported that 4-PBA
suppressed the migration of THP-1 monocytes induced by ER
stress-mediated inﬂammation by inhibiting BiP and PERK gene
expression. Therefore, 4-PBA could reduce tunicamycin-
induced RETN expression by inhibiting ER stress in THP-1
cells.
We found that the siRNA of either PERK, ATF4 or CHOP
inhibited tunicamycin-induced resistin mRNA in THP-1
human monocytes. The siRNA of ATF6, IRE1 or XBP1 had no
effect on the tunicamycin-induced resistin mRNA. Conversely,
the overexpression of ATF4 and CHOP increased resistin
mRNA. In addition, the induction of CHOP mRNA by tuni-
camycin appeared to be time-dependent up to 8 h, and then
declined to 24 h (data not shown), whereas that of resistin
mRNA reached a peak later at 24 h. Therefore, the PERK–
ATF4–CHOP pathway appears to be mainly involved in tuni-
camycin-induced resistin mRNA in THP-1 human monocytes.
Consistent with resistin mRNA, intracellular resistin protein
appeared to be enhanced by tunicamycin in THP-1 cells at
24 h. Paradoxically, resistin protein secretion was decreased by
tunicamycin in these cells. Most recently, Suragani et al.41
reported a similar discrepancy regarding tunicamycin treatment
in U937 human monocytes. They also showed that resistin was
retained in the ER as a possible chaperone of misfolded pro-
teins on tunicamycin treatment, which could account for the
decreased secretion of resistin. In addition, the secretion of
secretory proteins, such as resistin, could be decreased by tuni-
camycin as a result of its blocking effect on N-linked glycosyla-
tion. Under ER stress conditions, such as diabetes and obesity
in vivo, circulating resistin could be increased in the absence of
pharmacological effects of tunicamycin.
Several limitations should be noted. First, the effects of phar-
macological agents might not be limited to ER stress. Although
two known ER stress inducers, tunicamycin and thapsigargin,
similarly increased resistin mRNA in THP-1 human mono-
cytes, DTT, another ER stress inducer, paradoxically decreased
resistin mRNA, possibly through a different mechanism (Fig-
ure S3a,b). Second, the effect of tunicamycin on resistin mRNA
was assessed only in the THP-1 human monocytes cell line. It
appeared to be difﬁcult to assess the effect of tunicamycin on
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Figure 7 | Intracellular resistin protein appeared to be enhanced by
tunicamycin in THP-1 human monocytes. THP-1 cells were treated with
0.1 μg/mL tunicamycin for 6, 12 or 24 h. The resistin protein in the cell
lysate was measured using immune complex transfer enzyme
immunoassay (ICT-EIA) as described in the Materials and Methods. The
mean – standard error of the mean of six separate experiments with
triplicate samples is shown. ANOVA and Scheffe’s test were used for
statistical analyses. ANOVA; P = 0.021, Scheffe’s test; †P < 0.01 vs control
(0 h, tunicamycin [–]). In addition, the ratio of resistin protein in the cell
lysate treated with tunicamycin to that untreated at each time-point
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Figure 8 | Tunicamycin decreased resistin protein secretion from THP-1
human monocytes. THP-1 cells were treated with 0.1 μg/mL
tunicamycin for 6, 12 or 24 h. The resistin protein in the medium was
measured using immune complex transfer enzyme immunoassay (ICT-
EIA) as described in the Materials and Methods. The resistin protein of
the control (0 h, tunicamycin [–]) was defined as 1.0. The
mean – standard error of the mean of six separate experiments with
triplicate samples is shown. ANOVA and Scheffe’s test were used for
statistical analyses. ANOVA; P = 3.40 9 10-25, Scheffe’s test; ††P < 0.01,
†P < 0.05 vs control (0 h, tunicamycin [–]), *P < 0.01 (tunicamycin [+]
vs tunicamycin [–] at 12 and 24 h).
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resistin mRNA in isolated human monocytes, as resistin
mRNA was decreased to approximately one-ﬁfth of its initial
level in 24 h after the isolation of monocytes (Figure S5).
Nagaev et al.42 also reported the decrease in resistin mRNA
after isolation of human monocytes.
In summary, we have shown that ER stress induced by tuni-
camycin increased resistin mRNA through the PERK–ATF4–
CHOP pathway in THP-1 human monocytes. How ER stress
induces the expression of RETN, especially at the transcriptional
level, and the pathophysiological roles of resistin under condi-
tions of ER stress in humans remain unclear. Further studies
will be required to clarify these points.
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SUPPORTING INFORMATION
Additional Supporting Information may be found in the online version of this article:
Figure S1 | It was estimated that at least approximately 17% of the THP-1 cells overexpressed introduced genes by transfection.
Figure S2 | Calibration curves for resistin by immune complex transfer enzyme immunoassay.
Figure S3 | (a) Thapsigargin, the endoplasmic reticulum stress inducer, increased resistin messenger ribonucleic acid (mRNA) in
THP-1 human monocytes. (b) DTT, another ER stress inducer, paradoxically decreased resistin mRNA in THP-1 human mono-
cytes. ATF4, activating transcription factor 4; CHOP, CAAT/enhancer binding protein-a homologous protein; PERK, pancreatic
ER eukaryotic initiation factor 2a kinase; RETN, human resistin gene.
Figure S4 | Resistin messenger ribonucleic acid (mRNA) was not affected by the small interfering RNA of activating transcription
factor 6 (ATF6), inositol requiring enzyme 1 (IRE1) or X-box binding protein 1 (XBP1), whereas their own mRNA was reduced.
RETN, human resistin gene.
Figure S5 | Resistin messenger ribonucleic acid (mRNA) was decreased to approximately one-ﬁfth of its initial level in 24 h after
the isolation of monocytes. RETN, human resistin gene.
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